Using breast cancer as an example, we also demonstrated that the REACTIN algorithm can be used to investigate regulatory mechanisms governing different breast cancer subtypes by comparison with normal tissues, in addition to identifying TF activity associated with patient survival in their activities. Here, TF is linked to breast carcinoma.